Hyoungjun Ham

6PUBLICATIONS
114CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Microbial geneticsCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2025
A Dual Role for NKG7 in T-cell Cytotoxicity and Longevity.

Haidong Dong, Hyoungjun Ham, Whitney Barham

|Feb 14, 2025
Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control.

Hyoungjun Ham, Jacob B Hirdler, Daniel T Bihnam

|Sep 19, 2024
Germline mutations in a G protein identify signaling cross-talk in T cells.

Hyoungjun Ham, Huie Jing, Ian T Lamborn

|Mar 20, 2024
MADD regulates natural killer cell degranulation through Rab27a activation.

Michael J Medlyn, Easton Maeder, Claire Bradley

|Feb 12, 2024
Author Correction: GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Ann Y Park, Michael Leney-Greene, Matthew Lynberg

|Jan 03, 2024
GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.

Ann Y Park, Michael Leney-Greene, Matthew Lynberg

Pageof 1